Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Challenges with hippocampal MR spectroscopy as a surrogate for pre-radiotherapy assessment of neurocognitive impairment in patients with brain metastasis

I. Selingerova, K. Holikova, T. Chodur, L. Hynkova, P. Pospisil, M. Bulik, R. Belanova, K. Siffelova, I. Kolouskova, M. Slavik, P. Burkon, R. Hrstka, R. Jancalek, J. Sana, P. Slampa, T. Kazda

. 2024 ; 168 (3) : 206-215. [pub] 20240415

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24017558

AIM: Patients with multiple brain metastases (BM) benefit from hippocampal-avoiding whole brain radiotherapy (HA-WBRT), the challenging and less available form of WBRT. This study explores potential of pre-radiotherapy (pre-RT) hippocampal magnetic resonance spectroscopy (MRS) measuring hippocampal neuronal density as an imaging surrogate and predictive tool for assessing neurocognitive functions (NCF). METHODS: 43 BM patients underwent pre-RT hippocampal MRS. N-acetyl aspartate (NAA) concentration, a marker for neuronal density (weighted by creatine (Cr) and choline (Cho) concentrations), and neurocognitive function (NCF) tests (HVLT and BVMT) performed by certified psychologists were evaluated. Clinical variables and NAA concentrations were correlated with pre-RT NCFs. RESULTS: HVLT and BVMT subtests showed pre-RT deterioration except for BVMT recognition. Significantly better NCFs were observed in women in HVLT subsets. Significantly higher NAA/Cr + Cho was measured in women (median 0.63 vs. 0.55; P=0.048) in the left hippocampus (no difference in the right hippocampus). In men, a positive correlation (0.51, P=0.018) between total brain volume and HVLT-TR, between left hippocampal NAA/Cr + Cho and HVLT-R (0.45, P=0.063), and between right hippocampal NAA/Cr + Cho and BVMT-recognition (0.49, P=0.054) was observed. In women, a borderline significant negative correlation was observed between left hippocampal NAA/Cr + Cho and BVMT-TR (-0.43, P=0.076) and between right NAA/Cr + Cho and HVLT-DR (-0.42, P=0.051). CONCLUSION: Borderline statistically significant correlations were observed with speculative interpretation underlying the challenges of hippocampal MRS as a surrogate for neurocognitive impairment. Further studies need to be done to ascertain the opportunities for imaging predictors of benefit from memory sparing radiotherapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24017558
003      
CZ-PrNML
005      
20250507135844.0
007      
ta
008      
241004s2024 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2024.012 $2 doi
035    __
$a (PubMed)38623639
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Selingerová, Iveta $u Research Center for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0169224
245    10
$a Challenges with hippocampal MR spectroscopy as a surrogate for pre-radiotherapy assessment of neurocognitive impairment in patients with brain metastasis / $c I. Selingerova, K. Holikova, T. Chodur, L. Hynkova, P. Pospisil, M. Bulik, R. Belanova, K. Siffelova, I. Kolouskova, M. Slavik, P. Burkon, R. Hrstka, R. Jancalek, J. Sana, P. Slampa, T. Kazda
520    9_
$a AIM: Patients with multiple brain metastases (BM) benefit from hippocampal-avoiding whole brain radiotherapy (HA-WBRT), the challenging and less available form of WBRT. This study explores potential of pre-radiotherapy (pre-RT) hippocampal magnetic resonance spectroscopy (MRS) measuring hippocampal neuronal density as an imaging surrogate and predictive tool for assessing neurocognitive functions (NCF). METHODS: 43 BM patients underwent pre-RT hippocampal MRS. N-acetyl aspartate (NAA) concentration, a marker for neuronal density (weighted by creatine (Cr) and choline (Cho) concentrations), and neurocognitive function (NCF) tests (HVLT and BVMT) performed by certified psychologists were evaluated. Clinical variables and NAA concentrations were correlated with pre-RT NCFs. RESULTS: HVLT and BVMT subtests showed pre-RT deterioration except for BVMT recognition. Significantly better NCFs were observed in women in HVLT subsets. Significantly higher NAA/Cr + Cho was measured in women (median 0.63 vs. 0.55; P=0.048) in the left hippocampus (no difference in the right hippocampus). In men, a positive correlation (0.51, P=0.018) between total brain volume and HVLT-TR, between left hippocampal NAA/Cr + Cho and HVLT-R (0.45, P=0.063), and between right hippocampal NAA/Cr + Cho and BVMT-recognition (0.49, P=0.054) was observed. In women, a borderline significant negative correlation was observed between left hippocampal NAA/Cr + Cho and BVMT-TR (-0.43, P=0.076) and between right NAA/Cr + Cho and HVLT-DR (-0.42, P=0.051). CONCLUSION: Borderline statistically significant correlations were observed with speculative interpretation underlying the challenges of hippocampal MRS as a surrogate for neurocognitive impairment. Further studies need to be done to ascertain the opportunities for imaging predictors of benefit from memory sparing radiotherapy.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a hipokampus $x diagnostické zobrazování $x patologie $7 D006624
650    _2
$a ženské pohlaví $7 D005260
650    12
$a nádory mozku $x radioterapie $x sekundární $7 D001932
650    _2
$a lidé středního věku $7 D008875
650    12
$a magnetická rezonanční spektroskopie $x metody $7 D009682
650    _2
$a senioři $7 D000368
650    _2
$a kyselina aspartová $x analogy a deriváty $x metabolismus $7 D001224
650    _2
$a dospělí $7 D000328
650    _2
$a cholin $x metabolismus $7 D002794
650    _2
$a neuropsychologické testy $7 D009483
650    _2
$a kreatin $x metabolismus $7 D003401
650    _2
$a kraniální ozáření $x škodlivé účinky $7 D016371
650    _2
$a kognitivní dysfunkce $x etiologie $7 D060825
655    _2
$a časopisecké články $7 D016428
700    1_
$a Holíková, Klára $u Department of Medical Imaging, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 _AN122458
700    1_
$a Chodúr, Tomáš $u Unit of Clinical Psychology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0253929
700    1_
$a Hynková, Ludmila $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0077536
700    1_
$a Pospíšil, Petr $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0173603
700    1_
$a Bulik, Martin $u Department of Medical Imaging, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0323843
700    1_
$a Belanová, Renata $u Department of Radiology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0238000
700    1_
$a Šiffelová, Kamila $u Unit of Clinical Psychology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0253933
700    1_
$a Koloušková, Ivana $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0264098
700    1_
$a Slávik, Marek $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0139124
700    1_
$a Burkoň, Petr $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0233520
700    1_
$a Hrstka, Roman $u Research Center for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0077297
700    1_
$a Jančálek, Radim, $d 1975- $u Department of Neurosurgery, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Neurosurgery, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0037113
700    1_
$a Šána, Jiří $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $7 xx0165776
700    1_
$a Šlampa, Pavel, $d 1960- $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 mzk2004257405
700    1_
$a Kazda, Tomáš $u Research Center for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0213412
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 168, č. 3 (2024), s. 206-215
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38623639 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20241004 $b ABA008
991    __
$a 20250507135842 $b ABA008
999    __
$a ok $b bmc $g 2316478 $s 1229508
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 168 $c 3 $d 206-215 $e 20240415 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $n Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub $x MED00012606
LZP    __
$b NLK124 $a Pubmed-20241004

Find record

Citation metrics

Archiving options